HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Efficacy of gabapentin in the treatment of carpal tunnel syndrome].

AbstractBACKGROUND AND OBJECTIVE:
To evaluate the analgesic efficacy and safety of gabapentin in the treatment of carpal tunnel syndrome (CTS), as well as the electromyographic (EMG) evolution after 6 months.
PATIENTS AND METHOD:
A prospective study with a 6-month follow-up of patients with EMG diagnosis of primary CTS starting treatment with 1.800 mg/day of gabapentin. At baseline visit and after 6 months of treatment a complete clinical evaluation and an EMG study were performed. Adverse effects of gabapentin were also registered.
RESULTS:
Twenty-five patients were included, mean age (standard deviation) 58.88 (7.69) years. After 6 months of treatment, a statistically significant reduction of pain (p = 0.001) and improvement of severity of symptoms (p = 0.008) were observed, although functional capacity did not change. EMG was performed in 19 patients at 6 months. Compared to baseline EMG: 52.6% patients showed no changes in EMG findings, while 5.3% patients showed improvement and in 26.3% the EMG was normal. Progression was only seen in 15.8% of patients after 6 months of treatment. In 28% of the patients gabapentin was stopped because of side effects.
CONCLUSIONS:
In our series, gabapentin was effective in the reduction of pain and improvement of the severity of the symptoms. Results of EMG after 6 months of treatment showed no changes, with improvement and/or remission in 84.2% of the cases. The drug was safe and well tolerated.
AuthorsDelia Taverner, M Pilar Lisbona, Nuria Segalés, Elisa Docampo, Joan Calvet, Sonia Castro, Pere Benito
JournalMedicina clinica (Med Clin (Barc)) Vol. 130 Issue 10 Pg. 371-3 (Mar 22 2008) ISSN: 0025-7753 [Print] Spain
Vernacular TitleEficacia de la gabapentina en el tratamiento del síndrome del túnel carpiano.
PMID18381028 (Publication Type: Journal Article)
Chemical References
  • Amines
  • Analgesics
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • Gabapentin
Topics
  • Amines (therapeutic use)
  • Analgesics (therapeutic use)
  • Carpal Tunnel Syndrome (drug therapy)
  • Cyclohexanecarboxylic Acids (therapeutic use)
  • Electromyography
  • Female
  • Gabapentin
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • gamma-Aminobutyric Acid (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: